The causal role of chronic mental stress in the pathogenesis of essential hypertension

Stress and Cardiovascular Disease

Volumn 9781848824195, Issue , 2012, Pages 273-283

  Esler, Murray ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Aversive stressors for hypertension; Chronic mental stress; Experimental models of stress induced hypertension; Neurogenic hypertension; Pathogenesis of essential hypertension; Psychodynamic formulation; Public policy implementation; Sympathetic nervous system

Indexed keywords

EID: 84897862814     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-419-5_15     Document Type: Chapter

References (49)

1. Geisbock F. The nervous system. In: Julius S, Esler M, eds. Arterial Hypertension. Springfield: Charles C Thomas; 1976:xii.
2. Folkow B. Considering the "mind" as a primary cause. In: Robertson JIS, Zanchetti A, eds. Handbook of Hypertension, Hypertension in the Twentieth Century: Concepts and Achievements, vol. 22. Amsterdam: Elsevier; 2004:59-79.
3. Henry JP, Stephens PM, Santisteban GA. A model of psychosocial hypertension showing reversibility and progression of cardiovascular complications. Circ Res. 1975;36:156-164.
4. Henry JP, Wissam EN, Qian C, et al. Psychosocial stress can induce chronic hypertension in normotensive strains of rats. Hypertension. 1993;21:714-723.
5. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:348-504.
6. Folkow B. Physiological organization of neurohormonal responses to psychological stimuli: implications for health and disease. Ann Behav Med. 1993;15:234-236.
7. Julius S, Conway J. Hemodynamic studies in patients with borderline blood pressure elevation. Circulation. 1968;38:282-288.
8. Lund-Johansen P. Haemodynamics of essential hypertension. In: Swales JD, ed. Textbook of Hypertension. Oxford: Blackwell Science Publication; 1994:61-76.
9. Korner PI. Essential Hypertension and Its Causes. Neural and Non-Neural Mechanisms. Oxford: Oxford University Press; 2007.
10. Esler M, Julius S, Zweifler A, et al. Mild high-renin essential hypertension: a neurogenic human hypertension? N Engl J Med. 1977;296:405-411.
11. Light KC, Obrist PA. Cardiovascular reactivity to behavioral stress in young males with and without marginally elevated casual systolic pressures: comparison of clinic, home, and laboratory measures. Hypertension. 1980;2:802-808.
12. Harburg E, Erfurt JC, Hauenstein LS, et al. Socio-ecological stress, suppressed hostility, skin colour, and black-white male blood pressure: Detroit. Psychosom Med. 1973;35:276-296.
13. Perini C, Muller FB, Rauchfleisch U, et al. Hyperadrenergic borderline hypertension is characterized by suppressed aggression. J Cardiovasc Pharmacol. 1986;8(Suppl 5):53-56.
14. Henry JP, Grim CE. Psychosocial mechanisms of primary hypertension. J Hypertens. 1990; 8:783-793.
15. Deter HC, Bucholz K, Schorr U, Schachinger H, Turan S, Sharma AM. Psychophysiological reactivity of salt-sensitive normotensive subjects. J Hypertens. 1997;15:839-844.
16. Timio M, Verdechioa P, Rononi M, et al. Age and blood pressure changes: a 20 year follow-up study of nuns of a secluded order. Hypertension. 1988;12:457-461.
17. Steptoe A, Willemsen G. The influence of job control on ambulatory blood pressure and perceived stress over the working day in men and women from the Whitehall II cohort. J Hypertens. 2004;22:915-920.
18. Rosengren A, Hawken S, Ounpuu S, INTERHEART investigators, et al. Association of psychological risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): a case-control study. Lancet. 2004; 364:953-962.
19. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome. Br Med J. 2006;332:521-524.
20. Poulter NR, Khaw KT, Hopwood BEC, et al. The Kenyan Luo migration study: observations on the initiation of the rise in blood pressure. BMJ. 1990;300:967-972.
21. Davies SJ, Ghahramani P, Jackson PR, et al. Association of panic disorder and panic attacks with hypertension. Am J Med. 1999;107:310-316.
22. Alexander F. Emotional factors in essential hypertension. Psychosom Med. 1939;1:173-179.
23. Esler M. Hyperadrenergic and "labile" hypertension. In: Swales J, ed. Textbook of Hypertension. London: Blackwell; 1994:741-749.
24. Esler M, Eikelis N, Schlaich M, et al. Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol. 2008;35: 498-502.
25. Koepke JP, Jones S, DiBona GF. Stress increases renal nerve activity and decreases sodium excretion in Dahl rats. Hypertension. 1988;11:334-338.
26. DiBona GF, Kopp UC. Neural control of renal function: role in human hypertension. In: Laragh JH, Brenner BM, eds. Hypertension. Pathophysiology, Diagnosis and Management. New York: Raven; 1995:1349-1358.
27. Karasek R, Baker D, Marxer F, et al. Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men. Am J Public Health. 1981;71:694-705.
28. Karasek R, Theorell T, Schwartz JE, et al. Job characteristics in relation to prevalence of myocardial infarction in the US Health Examination (HES) and the Health and Nutrition Survey (HANES). Am J Public Health. 1988;78:910-918.
29. Pieper C, LaCroix AZ, Karasek RA. The relation of psychological dimensions of work with coronary heart disease risk factors: a meta-analysis of five United States data bases. Am J Epidemiol. 1989;129:483-499.
30. Siegrist J. Adverse health effects of high-effort/low-reward conditions. J Occup Health Psychol. 1996;71:694-705.
31. Klein S. The Secret Pulse of Time. Berlin: S. Fischer Verlag; 2006; (Translation, Avalon Publishing Group, USA, 2007).
32. Lambert E, Straznicky N, Schlaich MP, et al. Differing patterns of sympathoexcitation in normal weight and obesity-related hypertension. Hypertension. 2007;50:862-868.
33. Micutkova L, Krepsova K, Sabban E, et al. Modulation of catecholamine-synthesizing enzymes in the rat heart by repeated immobilization stress. Ann N Y Acad Sci. 2004;1018:424-429.
34. Esler M. The 2009 Carl Ludwig Lecture. Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanism to medical management. J Appl Physiol. 2010;108:227-237.
35. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R245-R253.
36. Esler M, Lambert E, Schlaich M. Point Counterpoint: chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol. 2010; 109:1996-1998.
37. Buhler FR, Laragh JH, Baer L, Vaughan ED, Brunner HR. Propranolol inhibition of renin secretion. N Engl J Med. 1972;287:1209-1214.
38. Esler M, Lambert G, Jennings G. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens. 1989;11(suppl 1):75-89.
39. Reudelhuber TL. Truncated prorenin comes up ... short. Hypertension. 2009;54:1216-1217.
40. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol. 2006;290:H1706-H1712.
41. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension. 1998;31:64-67.
42. Grassi G, Dell'Oro R, Quarti-Trevano F, et al. Neuroadrenergic and reflex abnormalities in patients with the metabolic syndrome. Diabetologia. 2005;48:1359-1365.
43. Greenwood JP, Stoker JB, Mary DASG. Single-unit sympathetic discharge. Quantitative assessment in human hypertensive disease. Circulation. 1999;100:1305-1310.
44. Krum H, Schlaich MP, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
45. Symplicity HTN-2 Investigators. Renal sympathetic denervationin patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomized controlled trial. Lancet. 2010;376:1903-1909.
46. Smithwick RH, Bush RD, Kinsey D, Whitelaw GP. Hypertension and associated cardiovascular disease; comparison of male and female mortality rates and their influence on selection of therapy. J Am Med Assoc. 1956;160:1023-1026.
47. Kivimaki M, Head J, Ferrie JE, et al. Hypertension is not the link between job strain and coronary heart disease in the Whitehall II Study. Am J Hypertens. 2007;20:1146-1153.
48. Rumantir MS, Vaz M, Jennings GL, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17:1125-1133.
49. Meredith IT, Friberg P, Jennings GL, et al. Regular exercise lowers renal but not cardiac sympathetic activity in man. Hypertension. 1991;18:575-582.